[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590101":3},{"organization":4,"outcomesModule":7,"designInfo":16,"detailedDescription":11,"studyPopulation":11,"armGroups":27,"interventions":40,"overallOfficials":48,"centralContacts":52,"locations":58,"responsibleParty":242,"collaborators":11,"id":244,"slug":11,"hasResults":245,"nctId":246,"briefTitle":247,"officialTitle":248,"acronym":11,"eligibilityCriteria":249,"healthyVolunteers":245,"sex":250,"minAge":251,"maxAge":252,"enrollmentInfo":253,"targetDuration":11,"studyType":256,"phases":257,"briefSummary":259,"conditions":260,"keywords":11,"overallStatus":61,"whyStopped":11,"lastUpdateSubmitDate":262,"lastUpdatePostDateStruct":263,"startDateStruct":266,"completionDateStruct":268,"leadSponsor":270,"locationsCount":271},{"fullName":5,"class":6},"Neurocrine Biosciences","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Score at Week 5",null,"Baseline, Week 5",[14],{"measure":15,"description":11,"timeFrame":12},"Change From Baseline in Clinical Global Impression - Severity (CGI-S) Score at Week 5",{"allocation":17,"interventionModel":18,"interventionModelDescription":11,"primaryPurpose":19,"observationalModel":11,"timePerspective":11,"maskingInfo":20},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":21,"maskingDescription":11,"whoMasked":22},"QUADRUPLE",[23,24,25,26],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR",[28,34],{"label":29,"type":30,"description":31,"interventionNames":32},"NBI-1117568","EXPERIMENTAL","Participants will receive NBI-1117568 once daily (QD) orally from Day 1 to Day 35 for a total of 5 weeks.",[33],"Drug: NBI-1117568",{"label":35,"type":36,"description":37,"interventionNames":38},"Placebo","PLACEBO_COMPARATOR","Participants will receive matching placebo QD orally from Day 1 to Day 35 for a total of 5 weeks.",[39],"Drug: Placebo",[41,45],{"type":42,"name":29,"description":43,"armGroupLabels":44,"otherNames":11},"DRUG","NBI-1117568 will be administered per schedule specified in the arm description.",[29],{"type":42,"name":35,"description":46,"armGroupLabels":47,"otherNames":11},"Placebo will be administered per schedule specified in the arm description.",[35],[49],{"name":50,"affiliation":5,"role":51},"Clinical Development Lead","STUDY_DIRECTOR",[53],{"name":54,"role":55,"phone":56,"phoneExt":11,"email":57},"Neurocrine Medical Information Call Center","CONTACT","877-641-3461","medinfo@neurocrine.com",[59,73,81,90,98,106,114,122,131,139,148,156,164,173,182,191,200,209,217,226,234],{"facility":60,"status":61,"city":62,"state":63,"zip":64,"country":65,"countryCode":66,"cosmosGeoPoint":67,"geoPoint":72,"contacts":11},"Neurocrine Clinical Site","RECRUITING","Bryant","Arkansas","72022","United States","US",{"type":68,"coordinates":69},"Point",[70,71],-92.48905,34.59593,{"lat":71,"lon":70},{"facility":60,"status":61,"city":74,"state":63,"zip":75,"country":65,"countryCode":66,"cosmosGeoPoint":76,"geoPoint":80,"contacts":11},"Little Rock","72211",{"type":68,"coordinates":77},[78,79],-92.28959,34.74648,{"lat":79,"lon":78},{"facility":60,"status":61,"city":82,"state":83,"zip":84,"country":65,"countryCode":66,"cosmosGeoPoint":85,"geoPoint":89,"contacts":11},"Anaheim","California","92805",{"type":68,"coordinates":86},[87,88],-117.9145,33.83529,{"lat":88,"lon":87},{"facility":60,"status":61,"city":91,"state":83,"zip":92,"country":65,"countryCode":66,"cosmosGeoPoint":93,"geoPoint":97,"contacts":11},"Pico Rivera","90660",{"type":68,"coordinates":94},[95,96],-118.09673,33.98307,{"lat":96,"lon":95},{"facility":60,"status":61,"city":99,"state":83,"zip":100,"country":65,"countryCode":66,"cosmosGeoPoint":101,"geoPoint":105,"contacts":11},"San Diego","92123",{"type":68,"coordinates":102},[103,104],-117.16472,32.71571,{"lat":104,"lon":103},{"facility":60,"status":61,"city":107,"state":83,"zip":108,"country":65,"countryCode":66,"cosmosGeoPoint":109,"geoPoint":113,"contacts":11},"Sherman Oaks","91403",{"type":68,"coordinates":110},[111,112],-118.44925,34.15112,{"lat":112,"lon":111},{"facility":60,"status":61,"city":115,"state":83,"zip":116,"country":65,"countryCode":66,"cosmosGeoPoint":117,"geoPoint":121,"contacts":11},"Torrance","90504",{"type":68,"coordinates":118},[119,120],-118.34063,33.83585,{"lat":120,"lon":119},{"facility":60,"status":61,"city":123,"state":124,"zip":125,"country":65,"countryCode":66,"cosmosGeoPoint":126,"geoPoint":130,"contacts":11},"Hollywood","Florida","33024",{"type":68,"coordinates":127},[128,129],-80.14949,26.0112,{"lat":129,"lon":128},{"facility":60,"status":61,"city":132,"state":124,"zip":133,"country":65,"countryCode":66,"cosmosGeoPoint":134,"geoPoint":138,"contacts":11},"Miami Lakes","33016",{"type":68,"coordinates":135},[136,137],-80.30866,25.90871,{"lat":137,"lon":136},{"facility":60,"status":61,"city":140,"state":141,"zip":142,"country":65,"countryCode":66,"cosmosGeoPoint":143,"geoPoint":147,"contacts":11},"Atlanta","Georgia","30331",{"type":68,"coordinates":144},[145,146],-84.38798,33.749,{"lat":146,"lon":145},{"facility":60,"status":61,"city":149,"state":141,"zip":150,"country":65,"countryCode":66,"cosmosGeoPoint":151,"geoPoint":155,"contacts":11},"Decatur","30030",{"type":68,"coordinates":152},[153,154],-84.29631,33.77483,{"lat":154,"lon":153},{"facility":60,"status":61,"city":157,"state":141,"zip":158,"country":65,"countryCode":66,"cosmosGeoPoint":159,"geoPoint":163,"contacts":11},"Snellville","30078",{"type":68,"coordinates":160},[161,162],-84.01991,33.85733,{"lat":162,"lon":161},{"facility":60,"status":61,"city":165,"state":166,"zip":167,"country":65,"countryCode":66,"cosmosGeoPoint":168,"geoPoint":172,"contacts":11},"Chicago","Illinois","60640",{"type":68,"coordinates":169},[170,171],-87.65005,41.85003,{"lat":171,"lon":170},{"facility":60,"status":61,"city":174,"state":175,"zip":176,"country":65,"countryCode":66,"cosmosGeoPoint":177,"geoPoint":181,"contacts":11},"Gaithersburg","Maryland","20877",{"type":68,"coordinates":178},[179,180],-77.20137,39.14344,{"lat":180,"lon":179},{"facility":60,"status":61,"city":183,"state":184,"zip":185,"country":65,"countryCode":66,"cosmosGeoPoint":186,"geoPoint":190,"contacts":11},"Watertown","Massachusetts","02472",{"type":68,"coordinates":187},[188,189],-71.18283,42.37093,{"lat":189,"lon":188},{"facility":60,"status":61,"city":192,"state":193,"zip":194,"country":65,"countryCode":66,"cosmosGeoPoint":195,"geoPoint":199,"contacts":11},"Marlton","New Jersey","08053",{"type":68,"coordinates":196},[197,198],-74.92183,39.89122,{"lat":198,"lon":197},{"facility":60,"status":61,"city":201,"state":202,"zip":203,"country":65,"countryCode":66,"cosmosGeoPoint":204,"geoPoint":208,"contacts":11},"Staten Island","New York","10314",{"type":68,"coordinates":205},[206,207],-74.13986,40.56233,{"lat":207,"lon":206},{"facility":60,"status":61,"city":210,"state":202,"zip":211,"country":65,"countryCode":66,"cosmosGeoPoint":212,"geoPoint":216,"contacts":11},"The Bronx","10461",{"type":68,"coordinates":213},[214,215],-73.86641,40.84985,{"lat":215,"lon":214},{"facility":60,"status":61,"city":218,"state":219,"zip":220,"country":65,"countryCode":66,"cosmosGeoPoint":221,"geoPoint":225,"contacts":11},"Austin","Texas","78754",{"type":68,"coordinates":222},[223,224],-97.74306,30.26715,{"lat":224,"lon":223},{"facility":60,"status":61,"city":227,"state":219,"zip":228,"country":65,"countryCode":66,"cosmosGeoPoint":229,"geoPoint":233,"contacts":11},"DeSoto","75115",{"type":68,"coordinates":230},[231,232],-96.85695,32.58986,{"lat":232,"lon":231},{"facility":60,"status":61,"city":235,"state":219,"zip":236,"country":65,"countryCode":66,"cosmosGeoPoint":237,"geoPoint":241,"contacts":11},"Houston","77043",{"type":68,"coordinates":238},[239,240],-95.36327,29.76328,{"lat":240,"lon":239},{"type":243,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100590101",false,"NCT06963034","NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia","A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1117568 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization","Key Inclusion Criteria:\n\n* Participant has a primary diagnosis of schizophrenia\n* Participant is experiencing an acute exacerbation or relapse of symptoms and currently warrants hospitalization.\n* Participants taking prohibited medications, including antipsychotics, must discontinue before study participation\n* Participant is willing and able to remain in an inpatient setting for the study duration, follow instructions, and comply with the protocol requirements\n\nKey Exclusion Criteria:\n\n* Participant has known hypersensitivity to any component of the formulation of NBI-1117568.\n* Participant has an unstable or poorly controlled medical condition or chronic disease\n* Participant is considered by the investigator to be at imminent risk of suicide or injury to self or others\n* Participant has a diagnosis of moderate or severe substance use disorder (with the exception of nicotine or caffeine dependence) within 6 months prior to screening\n* Participant has a positive alcohol test or drug screen for disallowed substances\n* Participants have a history of poor or suspected poor compliance in clinical research studies and\u002For in the investigator's opinion, the participant is not capable of adhering to the protocol requirements.\n\nNote: Other protocol-specified inclusion\u002Fexclusion criteria may apply.","ALL","18 Years","65 Years",{"count":254,"type":255},284,"ESTIMATED","INTERVENTIONAL",[258],"PHASE3","The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.",[261],"Schizophrenia","2026-03-05",{"date":264,"type":265},"2026-03-06","ACTUAL",{"date":267,"type":265},"2025-05-08",{"date":269,"type":255},"2027-10",{"name":5,"class":6},21]